Intravitreal bevacizumab injection versus subtreshold grid laser treatment for recurrent macular edema secondary to branch retinal vein occlusio
Not Applicable
- Conditions
- Recurrent macular edema secondary to branch retinal vein occlusion
- Registration Number
- JPRN-UMIN000005014
- Lead Sponsor
- Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
Not provided
Exclusion Criteria
1. detection of retinal capillary non-perfusion more than 5 disc diameter on fluorescein angiography coexistence of any other chorioretinal disease 2. presence of cataract or any other ocular conditions able to confound the results 3. uncontrolled systemic hypertension 4. peripheral vascular disease and history of thromboembolism, ischemic heart disease or stroke.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The reduction in the mean central retinal thickness evaluate on optical coherence tomography scan.
- Secondary Outcome Measures
Name Time Method The mean best-corrected visual acuity changes over the follow-up and the proportion of eyes that gained at least 15 letters (approximately 3 lines) at the 12-month examination.